|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,748.50 GBX | -0.63% |
|
-3.13% | +2.26% |
| 04-29 | WINNERS & LOSERS: Pharma in the red; DCC jumps after takeover approach | AN |
| 04-24 | Croda International Plc, Q1 2026 Sales/ Trading Statement Call, Apr 22, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 35.8 | +29.42% | 14 | ||||||
| 317.48 | +27.56% | 21 | ||||||
| 3,367.93 | +25.53% | 19 | ||||||
| 179.68 | +27.48% | 22 | ||||||
| 79 | -8.99% | 18 | ||||||
| 3,921.54 | +21.56% | 13 | ||||||
| 211.38 | +10.61% | 22 | ||||||
| 659.5 | -1.05% | 8 | ||||||
| 205,192.31 | -18.09% | 26 | ||||||
| 88.17 | +1.56% | 6 | ||||||
| 3,699.17 | +21.48% | 12 | ||||||
| 97.71 | +3.56% | 4 | ||||||
| 92.06 | +23.84% | 18 | ||||||
| 47.3 | +8.59% | 10 | ||||||
| 50.43 | -27.41% | 3 | ||||||
| 16.62 | -6.52% | 14 | ||||||
| 10,233.33 | -11.36% | 12 | ||||||
| 84.33 | +16.37% | 15 | ||||||
| - | 53.81 | +22.69% | 2 | |||||
| 21.99 | -14.65% | 14 | ||||||
| Average | 11,422.48 | +7.61% | 14 | ||||||
| Weighted average by Cap. | 9,751.68 | +12.48% | 16 |
- Stock Market
- Equities
- CRDA Stock
- Sector Croda International Plc
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition